التفاصيل البيبلوغرافية
| العنوان: |
Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) |
| المؤلفون: |
Centers for Disease Control (U.S.) Immunization Practices Advisory Committee. |
| المساهمون: |
Breiman, Robert F., Butler, Jay C., Nuorti, Pekka J., Centers for Disease Control and Prevention (U.S.), National Center for Infectious Diseases (U.S.) Division of Bacterial and Mycotic Diseases. |
| بيانات النشر: |
U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC) |
| المجموعة: |
CDC Stacks (Centers for Disease Control and Prevention) |
| مصطلحات موضوعية: |
Pneumonia, Pneumococcal--Prevention, Pneumococcal--United States--Prevention, Pneumococcal--Vaccination, Pneumococcal Infections--epidemiology, Pneumococcal Infections--prevention & control, Pneumococcal Vaccines, Vaccination--utilization, Vaccination--utilization--United States, Vaccines, Conjugate, RA407.A1 M6 v.46 no.RR-8, HE 20.7009/2-2:46/8 |
| جغرافية الموضوع: |
United States |
| الوصف: |
" This report updates the last recommendations by the Advisory Committee on Immunization Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989;38:64-8,73-6). ACIP recommends that the vaccine be used more extensively and administered to all persons in the following groups: a) persons aged greater than or equal to 65 years, b) immunocompetent persons aged greater than or equal to 2 years who are at increased risk for illness and death associated with pneumococcal disease because of chronic illness, c) persons aged greater than or equal to 2 years with functional or anatomic asplenia, d) persons aged greater than or equal to 2 years living in environments in which the risk for disease is high, and e) immunocompromised persons aged greater than or equal to 2 years who are at high risk for infection. This report contains updated information regarding a) antimicrobial resistance among pneumococci, b) vaccine effectiveness and cost-effectiveness, c) indications for vaccination, d) guidelines for revaccination, e) strategies for improving delivery of vaccine, and f) development of pneumococcal conjugate vaccine." - p. 1 ; Cover title. ; "April 4, 1997." ; The following CDC staff members prepared this report: Pekka J. Nuorti, Jay C. Butler, Robert F. Breiman, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases ; Also available via the World Wide Web. ; Includes bibliographical references (p. 19-24). |
| نوع الوثيقة: |
text |
| وصف الملف: |
iv, 24 p.; 22 cm.; print |
| اللغة: |
English |
| العلاقة: |
http://stacks.cdc.gov/view/cdc/5708Test/ |
| الإتاحة: |
http://stacks.cdc.gov/view/cdc/5708Test/ |
| رقم الانضمام: |
edsbas.386F5D95 |
| قاعدة البيانات: |
BASE |
